<DOC>
	<DOCNO>NCT01330381</DOCNO>
	<brief_summary>To evaluate efficacy prucalopride compare placebo treatment functional constipation paediatric population , age ≥ 6 month &lt; 18 year . A 16-week open-label comparator ( PEG ) control part follow , document safety tolerability 24 week .</brief_summary>
	<brief_title>Prucalopride Pediatric Subjects With Functional Constipation</brief_title>
	<detailed_description />
	<mesh_term>Constipation</mesh_term>
	<criteria>Main 1 . Boys girl , age ≥ 6 month &lt; 18 year . 2 . Subjects confirm diagnosis functional constipation define Rome III criterion . Main 1 . Children underlie GI abnormality cause defecation disorder . 2 . Constipation think druginduced . 3 . Subjects suffer secondary cause chronic constipation .</criteria>
	<gender>All</gender>
	<minimum_age>6 Months</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>January 2014</verification_date>
</DOC>